SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-022535
Filing Date
2023-08-08
Accepted
2023-08-08 16:32:55
Documents
52
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dffn20230630_10q.htm   iXBRL 10-Q 684462
2 EXHIBIT 31.1 ex_554787.htm EX-31.1 9012
3 EXHIBIT 31.2 ex_554788.htm EX-31.2 8569
4 EXHIBIT 32.1 ex_554789.htm EX-32.1 4762
5 EXHIBIT 32.2 ex_554790.htm EX-32.2 5089
11 image01.jpg GRAPHIC 6002
  Complete submission text file 0001437749-23-022535.txt   3515196

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA dffn-20230630.xsd EX-101.SCH 33325
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dffn-20230630_def.xml EX-101.DEF 227827
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE dffn-20230630_lab.xml EX-101.LAB 200868
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dffn-20230630_pre.xml EX-101.PRE 249257
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dffn-20230630_cal.xml EX-101.CAL 19386
46 EXTRACTED XBRL INSTANCE DOCUMENT dffn20230630_10q_htm.xml XML 478834
Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37942 | Film No.: 231151974
SIC: 2834 Pharmaceutical Preparations